Home > > > > Report Detail

Global Biosimilar Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 04-May-2020
No. of pages: 118
Inquire Before Buying

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we're using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilar Drug 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Biosimilar Drug 3900 industry.

Based on our recent survey, we have several different scenarios about the Biosimilar Drug 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biosimilar Drug 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilar Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilar Drug market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Biosimilar Drug market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Biosimilar Drug market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilar Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilar Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilar Drug market.

The following manufacturers are covered in this report:

- Amgen

- Eli Lilly

- Novartis

- CP Guojian Pharma

- Biotech Pharma

- ...

Biosimilar Drug Breakdown Data by Type

- Injection

- Tablets

- Other Types

Biosimilar Drug Breakdown Data by Application

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

- Other Application

Global Biosimilar Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Biosimilar Drug Product Introduction
1.2 Market Segments
1.3 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilar Drug Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Tablets
1.4.4 Other Types
1.5 Market by Application
1.5.1 Global Biosimilar Drug Market Size Growth Rate by Application
1.5.2 Ankylosing Spondylitis
1.5.3 Tumor
1.5.4 Rheumatoid Arthrtis
1.5.5 Cardiovascular
1.5.6 Other Application
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilar Drug Industry
1.6.1.1 Biosimilar Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilar Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilar Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Drug Revenue 2015-2026
2.1.2 Global Biosimilar Drug Sales 2015-2026
2.2 Biosimilar Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilar Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilar Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biosimilar Drug Competitor Landscape by Players
3.1 Biosimilar Drug Sales by Manufacturers
3.1.1 Biosimilar Drug Sales by Manufacturers (2015-2020)
3.1.2 Biosimilar Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilar Drug Revenue by Manufacturers
3.2.1 Biosimilar Drug Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilar Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilar Drug Revenue in 2019
3.2.5 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilar Drug Price by Manufacturers
3.4 Biosimilar Drug Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Drug Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biosimilar Drug Market Size by Type (2015-2020)
4.1.1 Global Biosimilar Drug Sales by Type (2015-2020)
4.1.2 Global Biosimilar Drug Revenue by Type (2015-2020)
4.1.3 Biosimilar Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilar Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilar Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilar Drug Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilar Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilar Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Biosimilar Drug Market Size by Application (2015-2020)
5.1.1 Global Biosimilar Drug Sales by Application (2015-2020)
5.1.2 Global Biosimilar Drug Revenue by Application (2015-2020)
5.1.3 Biosimilar Drug Price by Application (2015-2020)
5.2 Biosimilar Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilar Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilar Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilar Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biosimilar Drug by Country
6.1.1 North America Biosimilar Drug Sales by Country
6.1.2 North America Biosimilar Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilar Drug Market Facts & Figures by Type
6.3 North America Biosimilar Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country
7.1.2 Europe Biosimilar Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilar Drug Market Facts & Figures by Type
7.3 Europe Biosimilar Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biosimilar Drug by Region
8.1.1 Asia Pacific Biosimilar Drug Sales by Region
8.1.2 Asia Pacific Biosimilar Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilar Drug Market Facts & Figures by Type
8.3 Asia Pacific Biosimilar Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biosimilar Drug by Country
9.1.1 Latin America Biosimilar Drug Sales by Country
9.1.2 Latin America Biosimilar Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilar Drug Market Facts & Figures by Type
9.3 Central & South America Biosimilar Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar Drug by Country
10.1.1 Middle East and Africa Biosimilar Drug Sales by Country
10.1.2 Middle East and Africa Biosimilar Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilar Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Biosimilar Drug Products Offered
11.1.5 Amgen Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description, Business Overview and Total Revenue
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Biosimilar Drug Products Offered
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Biosimilar Drug Products Offered
11.3.5 Novartis Recent Development
11.4 CP Guojian Pharma
11.4.1 CP Guojian Pharma Corporation Information
11.4.2 CP Guojian Pharma Description, Business Overview and Total Revenue
11.4.3 CP Guojian Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CP Guojian Pharma Biosimilar Drug Products Offered
11.4.5 CP Guojian Pharma Recent Development
11.5 Biotech Pharma
11.5.1 Biotech Pharma Corporation Information
11.5.2 Biotech Pharma Description, Business Overview and Total Revenue
11.5.3 Biotech Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biotech Pharma Biosimilar Drug Products Offered
11.5.5 Biotech Pharma Recent Development
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Biosimilar Drug Products Offered
11.1.5 Amgen Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biosimilar Drug Market Estimates and Projections by Region
12.1.1 Global Biosimilar Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilar Drug Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilar Drug Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilar Drug Sales Forecast (2021-2026)
12.2.2 North America: Biosimilar Drug Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilar Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilar Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilar Drug Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilar Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilar Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilar Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilar Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilar Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilar Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilar Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilar Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilar Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilar Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilar Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilar Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilar Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilar Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biosimilar Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Biosimilar Drug Market Segments
Table 2. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilar Drug Market Size Growth Rate by Type 2020-2026 (K Dose) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Tablets
Table 6. Major Manufacturers of Other Types
Table 7. COVID-19 Impact Global Market: (Four Biosimilar Drug Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biosimilar Drug Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biosimilar Drug Players to Combat Covid-19 Impact
Table 12. Global Biosimilar Drug Market Size Growth Rate by Application 2020-2026 (K Dose)
Table 13. Global Biosimilar Drug Market Size by Region (K Dose) & (US$ Million): 2020 VS 2026
Table 14. Global Biosimilar Drug Sales by Regions 2015-2020 (K Dose)
Table 15. Global Biosimilar Drug Sales Market Share by Regions (2015-2020)
Table 16. Global Biosimilar Drug Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Biosimilar Drug Sales by Manufacturers (2015-2020) (K Dose)
Table 18. Global Biosimilar Drug Sales Share by Manufacturers (2015-2020)
Table 19. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2019)
Table 21. Biosimilar Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Biosimilar Drug Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Biosimilar Drug Price (2015-2020) (USD/Dose)
Table 24. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Biosimilar Drug Product Type
Table 26. Date of International Manufacturers Enter into Biosimilar Drug Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 29. Global Biosimilar Drug Sales Share by Type (2015-2020)
Table 30. Global Biosimilar Drug Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Biosimilar Drug Revenue Share by Type (2015-2020)
Table 32. Biosimilar Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 33. Global Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 34. Global Biosimilar Drug Sales Share by Application (2015-2020)
Table 35. North America Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 36. North America Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 37. North America Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 39. North America Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 40. North America Biosimilar Drug Sales Market Share by Type (2015-2020)
Table 41. North America Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 42. North America Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 43. Europe Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 44. Europe Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 45. Europe Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 47. Europe Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 48. Europe Biosimilar Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 50. Europe Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Biosimilar Drug Sales by Region (2015-2020) (K Dose)
Table 52. Asia Pacific Biosimilar Drug Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Biosimilar Drug Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Biosimilar Drug Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 56. Asia Pacific Biosimilar Drug Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 58. Asia Pacific Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 59. Latin America Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 60. Latin America Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 63. Latin America Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 64. Latin America Biosimilar Drug Sales Market Share by Type (2015-2020)
Table 65. Latin America Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 66. Latin America Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 68. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 72. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 74. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Major Businesses
Table 77. Amgen Biosimilar Drug Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Amgen Product
Table 79. Amgen Recent Development
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Major Businesses
Table 82. Eli Lilly Biosimilar Drug Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Eli Lilly Product
Table 84. Eli Lilly Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Major Businesses
Table 87. Novartis Biosimilar Drug Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Novartis Product
Table 89. Novartis Recent Development
Table 90. CP Guojian Pharma Corporation Information
Table 91. CP Guojian Pharma Description and Major Businesses
Table 92. CP Guojian Pharma Biosimilar Drug Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. CP Guojian Pharma Product
Table 94. CP Guojian Pharma Recent Development
Table 95. Biotech Pharma Corporation Information
Table 96. Biotech Pharma Description and Major Businesses
Table 97. Biotech Pharma Biosimilar Drug Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Biotech Pharma Product
Table 99. Biotech Pharma Recent Development
Table 100. Global Biosimilar Drug Sales Forecast by Regions (2021-2026) (K Dose)
Table 101. Global Biosimilar Drug Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Biosimilar Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Biosimilar Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Biosimilar Drug Sales Forecast by Country (2021-2026) (K Dose)
Table 105. North America: Biosimilar Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Biosimilar Drug Sales Forecast by Country (2021-2026) (K Dose)
Table 107. Europe: Biosimilar Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Biosimilar Drug Sales Forecast by Region (2021-2026) (K Dose)
Table 109. Asia Pacific: Biosimilar Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Biosimilar Drug Sales Forecast by Country (2021-2026) (K Dose)
Table 111. Latin America: Biosimilar Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Biosimilar Drug Sales Forecast by Country (2021-2026) (K Dose)
Table 113. Middle East and Africa: Biosimilar Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Biosimilar Drug Players
Table 118. Biosimilar Drug Customers List
Table 119. Biosimilar Drug Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Biosimilar Drug Report Years Considered
Figure 13. Global Biosimilar Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Biosimilar Drug Sales 2015-2026 (K Dose)
Figure 15. Global Biosimilar Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Biosimilar Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Biosimilar Drug Sales Market Share by Region in 2019
Figure 18. Global Biosimilar Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Biosimilar Drug Revenue Market Share by Region in 2019
Figure 20. Global Biosimilar Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Biosimilar Drug Revenue in 2019
Figure 22. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Biosimilar Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Biosimilar Drug Sales Market Share by Type in 2019
Figure 25. Global Biosimilar Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Biosimilar Drug Revenue Market Share by Type in 2019
Figure 27. Global Biosimilar Drug Market Share by Price Range (2015-2020)
Figure 28. Global Biosimilar Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Biosimilar Drug Sales Market Share by Application in 2019
Figure 30. Global Biosimilar Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Biosimilar Drug Revenue Market Share by Application in 2019
Figure 32. North America Biosimilar Drug Sales Growth Rate 2015-2020 (K Dose)
Figure 33. North America Biosimilar Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Biosimilar Drug Sales Market Share by Country in 2019
Figure 35. North America Biosimilar Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 37. U.S. Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 39. Canada Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Biosimilar Drug Market Share by Type in 2019
Figure 41. North America Biosimilar Drug Market Share by Application in 2019
Figure 42. Europe Biosimilar Drug Sales Growth Rate 2015-2020 (K Dose)
Figure 43. Europe Biosimilar Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Biosimilar Drug Sales Market Share by Country in 2019
Figure 45. Europe Biosimilar Drug Revenue Market Share by Country in 2019
Figure 46. Germany Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 47. Germany Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 49. France Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 51. U.K. Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 53. Italy Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 55. Russia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Biosimilar Drug Market Share by Type in 2019
Figure 57. Europe Biosimilar Drug Market Share by Application in 2019
Figure 58. Asia Pacific Biosimilar Drug Sales Growth Rate 2015-2020 (K Dose)
Figure 59. Asia Pacific Biosimilar Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Biosimilar Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Biosimilar Drug Revenue Market Share by Region in 2019
Figure 62. China Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 63. China Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 65. Japan Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 67. South Korea Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 69. India Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 71. Australia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 73. Taiwan Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 75. Indonesia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 77. Thailand Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 79. Malaysia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 81. Philippines Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 83. Vietnam Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Biosimilar Drug Market Share by Type in 2019
Figure 85. Asia Pacific Biosimilar Drug Market Share by Application in 2019
Figure 86. Latin America Biosimilar Drug Sales Growth Rate 2015-2020 (K Dose)
Figure 87. Latin America Biosimilar Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Biosimilar Drug Sales Market Share by Country in 2019
Figure 89. Latin America Biosimilar Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 91. Mexico Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 93. Brazil Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 95. Argentina Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Biosimilar Drug Market Share by Type in 2019
Figure 97. Latin America Biosimilar Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Biosimilar Drug Sales Growth Rate 2015-2020 (K Dose)
Figure 99. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Biosimilar Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Biosimilar Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 103. Turkey Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 105. Saudi Arabia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. UAE Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 107. UAE Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Biosimilar Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Biosimilar Drug Market Share by Application in 2019
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. CP Guojian Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Biotech Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Biosimilar Drug Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 116. North America Biosimilar Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Biosimilar Drug Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 118. Europe Biosimilar Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Biosimilar Drug Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 120. Asia Pacific Biosimilar Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Biosimilar Drug Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 122. Latin America Biosimilar Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Biosimilar Drug Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 124. Middle East and Africa Biosimilar Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs